We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
-9.93%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$73.6M
Cap. Flow
-$47.3M
Cap. Flow %
-22.15%
Top 10 Hldgs %
55.28%
Holding
36
New
–
Increased
5
Reduced
19
Closed
8

Top Buys

1
BMY icon
Bristol-Myers Squibb
BMY
+$49.5K
2
FNV icon
Franco-Nevada
FNV
+$35.5K
3
RGLD icon
Royal Gold
RGLD
+$34.5K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$24.5K
5
UNH icon
UnitedHealth
UNH
+$21.6K

Top Sells

1
WCC
WESCO International
WCC
+$10.3M
2
MCK icon
McKesson
MCK
+$8.85M
3
LMT icon
Lockheed Martin
LMT
+$8.65M
4
MTH icon
Meritage Homes
MTH
+$7.69M
5
LEN icon
Lennar Class A
LEN
+$5.59M

Sector Composition

1 Healthcare 21.61%
2 Energy 20.63%
3 Technology 14%
4 Industrials 11.09%
5 Consumer Discretionary 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQT icon
1
EQT Corp
EQT
$30.9B
$15.3M 7.16%
444,702
-2,111
-0.5% -$87K
OXY icon
2
Occidental Petroleum
OXY
$53.4B
$13.7M 6.4%
231,962
-645
-0.3% -$39.6K
UNH icon
3
UnitedHealth
UNH
$384B
$12.6M 5.9%
24,524
+43
+0.2% +$21.6K
MCK icon
4
McKesson
MCK
$98.5B
$12.4M 5.79%
37,924
-27,661
-42% -$8.85M
RUSHA icon
5
Rush Enterprises Class A
RUSHA
$6.19B
$11.6M 5.43%
360,609
– –
DOW icon
6
Dow Inc
DOW
$21.1B
$11.2M 5.25%
217,376
-702
-0.3% -$45K
SLB icon
7
SLB Ltd
SLB
$70.4B
$11.1M 5.2%
310,543
-754
-0.2% -$31.4K
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.06T
$10.2M 4.76%
37,194
+78
+0.2% +$24.5K
CVS icon
9
CVS Health
CVS
$136B
$10.1M 4.73%
108,923
-114
-0.1% -$11.1K
KEX icon
10
Kirby Corp
KEX
$7.67B
$9.97M 4.67%
163,915
-1,484
-0.9% -$96.6K
BMY icon
11
Bristol-Myers Squibb
BMY
$124B
$9.82M 4.6%
127,556
+650
+0.5% +$49.5K
AMLP icon
12
Alerian MLP ETF
AMLP
$12.7B
$9.68M 4.53%
281,100
-593
-0.2% -$22.8K
TEN
13
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$9.47M 4.44%
552,169
-9,050
-2% -$153K
MTZ icon
14
MasTec
MTZ
$26.9B
$9.16M 4.29%
127,895
-1,164
-0.9% -$90.7K
MSFT icon
15
Microsoft
MSFT
$2.98T
$8.02M 3.76%
31,241
-74
-0.2% -$20.1K
AVGO icon
16
Broadcom
AVGO
$1.78T
$7.81M 3.66%
160,730
-600
-0.4% -$33.7K
AAPL icon
17
Apple
AAPL
$4.89T
$7.56M 3.54%
55,317
-210
-0.4% -$31.8K
MCHP icon
18
Microchip Technology
MCHP
$44.4B
$6.5M 3.04%
111,873
-402
-0.4% -$26.6K
NMIH icon
19
NMI Holdings
NMIH
$3.23B
$4.87M 2.28%
292,528
-40,753
-12% -$741K
FNV icon
20
Franco-Nevada
FNV
$38.2B
$4.67M 2.18%
35,453
+240
+0.7% +$35.5K
WAB icon
21
Wabtec
WAB
$44.8B
$4.54M 2.13%
55,375
-167
-0.3% -$14.9K
RGLD icon
22
Royal Gold
RGLD
$16.2B
$4.5M 2.11%
42,103
+279
+0.7% +$34.5K
CCJ icon
23
Cameco
CCJ
$38B
$3.4M 1.59%
161,565
-603
-0.4% -$15.2K
GLD icon
24
SPDR Gold Trust
GLD
$130B
$2.47M 1.16%
14,645
-916
-6% -$160K
PFE icon
25
Pfizer
PFE
$143B
$1.27M 0.59%
24,164
-215
-0.9% -$11K
1
2

Similar funds

AC
Attestor Capital Grand Cayman, Cayman Islands $380M AUM
MW
Marks Wealth Annapolis, Maryland $380M AUM 40.02% 1-Year Est. Return
EAM
Empirical Asset Management Wellesley, Massachusetts $379M AUM 24.52% 1-Year Est. Return
RWA
Rooted Wealth Advisors Bourbonnais, Illinois $379M AUM 13.75% 1-Year Est. Return
CSWG
Cardinal Strategic Wealth Guidance Louisville, Kentucky $379M AUM 19.59% 1-Year Est. Return
BP
BWM Planning The Woodlands, Texas $379M AUM 21.72% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return

Muhlenkamp & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Muhlenkamp & Co held 36 positions worth $214M, down 26% from $287M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Muhlenkamp & Co withdrew a net $47.3M in Q2 2022, closing 8 positions and reducing 19 holdings. Its most notable exit was WESCO International, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Energy and Technology.

Against the trend, Muhlenkamp & Co added an estimated $49.5K to Bristol-Myers Squibb.

  • Muhlenkamp & Co added most to Bristol-Myers Squibb in Q2 2022, an estimated $49.5K increase.
  • Muhlenkamp & Co's biggest Q2 2022 reduction was McKesson, cutting an estimated $8.85M.
  • Muhlenkamp & Co fully exited WESCO International in Q2 2022, selling an estimated $10.3M.
  • Muhlenkamp & Co's ten largest holdings make up 55% of its $214M portfolio in Q2 2022.
  • Muhlenkamp & Co opened 0 new positions and closed 8 in Q2 2022.
  • Muhlenkamp & Co's portfolio value fell 26% quarter-over-quarter to $214M.

Based on Muhlenkamp & Co's 13F filing for Q2 2022, filed 18 Jul 2022.